Literature DB >> 3189501

Clinical evaluation of the Non-Contact Tonometer Mark II.

B C Chauhan1, D B Henson.   

Abstract

The purpose of this investigation was to test the reliability of the American Optical Non-Contact Tonometer Mark II (NCT II) using the Goldmann Applanation Tonometer (GAT) as the validating instrument. The sample contained 102 consecutive patients from our University Eye Clinic, of whom one-half had 4 NCT II measurements first, followed by 4 GAT measurements; the other one-half had 4 GAT measurements first, followed by 4 NCT II measurements. No significant change in intraocular pressure (IOP) was noted over the measurement sequence with either instrument. There was no significant difference between paired NCT II and GAT readings when the NCT II was used first; however, a highly significant difference between paired readings was obtained when the GAT was used first, indicating that the GAT measurement produced a delayed reduction in the IOP. This effect did not occur with the NCT II. Although the NCT II is shown to have a good overall reliability when compared to the GAT in both protocols, the agreement between any two tonometers may be influenced greatly by the very process of taking a measurement and by the dynamic nature of the IOP.

Entities:  

Mesh:

Year:  1988        PMID: 3189501     DOI: 10.1097/00006324-198809000-00010

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  3 in total

1.  On the precision and reliability of IOP measurements.

Authors:  J M Gilchrist
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

2.  Clinical comparison of Pulsair non-contact tonometer and Goldmann applanation tonometer in Indian population.

Authors:  Shalini Mohan; Satyaprakash Tiwari; Arvind Jain; Jaya Gupta; Surendra Kumar Sachan
Journal:  J Optom       Date:  2013-07-26

3.  Performance of the PT100 noncontact tonometer in healthy eyes.

Authors:  Turki M AlMubrad
Journal:  Clin Ophthalmol       Date:  2011-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.